Mirati Therapeutics | MRTX - Debt


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

API Features Documentation Interested? Click here to contact us
Please Paste this Code in your Website
width
height
 Preview

Mirati Therapeutics

Mirati Therapeutics reported $0 in Debt for its fiscal quarter ending in June of 2022.


Debt Change
Alnylam Pharmaceuticals ALNY:US USD 1.02B 945K
Amgen AMGN:US USD 61.6B 22.65B
Astellas Pharma 4503:JP JPY 320.06B 9.1B
AstraZeneca AZN:LN USD 31.5B 2.27B
Bayer BAYN:GR EUR 43.3B 1.65B
BioCryst Pharmaceuticals BCRX:US USD 746.93M 13.65M
Bristol-Myers Squibb BMY:US USD 37.83B 1.49B
Eisai 4523:JP JPY 126.1B 24.02B
Eli Lilly LLY:US USD 18.88B 2.64B
GlaxoSmithKline GSK:LN GBP 20.9B 82M
Incyte Corp INCY:US USD 32.85M 414K
Ionis Pharmaceuticals IONS:US USD 1.19B 2.36M
J&J JNJ:US USD 52.91B 13.25B
Moderna Inc MRNA:US USD 984M 89M
Novartis NOVN:VX USD 29.15B 1.24B
Puma Biotechnology PBYI:US USD 98.62M 316K
Roche Holding ROG:VX 25.35B 2.4B
Sarepta Therapeutics SRPT:US USD 1.23B 310.01M
Spectrum Pharmaceuticals SPPI:US USD 28.84M 174K
Takeda 4502:JP JPY 4.38T 95.44B